Realcan Pharmaceutical Group Co., Ltd.

¥2.82As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002589Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (15.25%)
Div yield 0.07%
ROE 0.95%
Medical Distribution
Beta (5Y) 0.32
PE TTM 342.7
TSR TTM (2.01%)
Mkt cap ¥4.146B
ROIC 1.43%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥2.91
3.08%
(86.24%)
Hold 9|4|4|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.03
0.03
0.03
0.04
2.12%
8.86%
3.44%
15.70%
Revenue¥M
340.8
347.4
355.0
367.0
5.39%
5.95%
8.73%
7.47%
Peers (US$621.4M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.214
(0.242)
(0.214)
EBIT/Intx
3.215
0.040
0.043
Own earn%
(62.37)
52.87
28.48
Sh yield%
20.05
42.46
42.79
Owners
Insiders/Inst%
7.68
56.54
Short interest%
5.55
SBC / revenue%
5.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
3–9
$1 testx
—
Incr. ROIC%
7